483 Response AMAG Pharmaceuticals Oct 2008

Megan Haggerty FDA, Ramon Martinez FDA$119.00 - Available Now

FDA investigators audited the AMAG Pharmaceuticals - Cambridge, MA, United States facility and issued inspectional observation (via FDA 483) on 14 Oct 2008.

Product details

  • Category:
  • Inspection end: 14 Oct 2008
  • Location: Cambridge, United States
  • FEI: 1220373
Add To Cart